Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 09:41 am Purchase | 2023-12-31 | 13G | ARBUTUS BIOPHARMA CORP ABUS | BlackRock, Inc. BLK | 10,390,300 6.200% | 1,689,908 (+19.42%) | Filing |
| 2023-11-21 08:00 am Purchase | 2023-11-21 | 13G | ARBUTUS BIOPHARMA CORP ABUS | Two Seas Capital LP | 9,503,103 5.700% | 9,503,103 (New Position) | Filing History |
| 2023-09-11 5:07 pm Purchase | 2023-09-01 | 13G | ARBUTUS BIOPHARMA CORP ABUS | Whitefort Capital Master Fund, LP | 10,013,899 6.000% | 10,013,899 (New Position) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | ARBUTUS BIOPHARMA CORP ABUS | BlackRock, Inc. BLK | 8,700,392 5.600% | 8,700,392 (New Position) | Filing |
| 2022-02-14 09:36 am Sale | 2021-12-31 | 13G | ARBUTUS BIOPHARMA CORP ABUS | RTW Investments, LP | 2,504,493 1.700% | -3,473,862 (-58.11%) | Filing History |
| 2021-10-20 5:13 pm Purchase | 2021-10-18 | 13D | ARBUTUS BIOPHARMA CORP ABUS | Roivant Sciences Ltd. ROIV | 38,847,462 29.100% | 22,833,922 (+142.59%) | Filing History |